(University of Calgary) A research team from the Cumming School of Medicine's Hotchkiss Brain Institute have published important research which will benefit individuals who are in the early stages of multiple sclerosis (MS). Study results show that a common acne medication, minocycline, can help prevent MS symptoms from developing into full-blown MS in patients who are in the early stages of the disease. The work will be published Thursday, June 1 in the New England Journal of Medicine.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2srZ0HF
No comments:
Post a Comment